Home

Ospraie Management, Inc.

CIK 1392203 · last filed 2020-05-01

Ospraie Management, Inc. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for MBII, was dated May 1, 2020. The firm reports its address in New York, NY. 18 SEC filings were submitted jointly with Ospraie Holding I, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
320 PARK AVENUE
27TH FLOOR
NEW YORK, NY 10022
Phone
(212) 602-5000
Related Filers
Ospraie Holding I, L.P. — 18 joint filings, latest 2026-06-08
Ospraie Management, LLC — 18 joint filings, latest 2026-06-08
Dwight Anderson — 17 joint filings, latest 2026-06-08
Ospraie Ag Science LLC — 10 joint filings, latest 2022-07-15
Ospraie Real Assets Fund LP — 4 joint filings, latest 2026-06-08
CK Wheels LLC — same reported address
Eos Partners SBIC III, L.P. — same reported address
OEP III Co-Investors, L.P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MARRONE BIO INNOVATIONS INC (MBII) Delisted Director 51,567,942 $0.80 $41.16M $0 1 2020-05-01

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-05-01 MARRONE BIO INNOVATIONS INC (MBII) Delisted Mixed +12,338,830 $9.25M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.